Morgan Stanley Maintains Equal-Weight on Global Blood Therapeutics, Raises Price Target to $80

Morgan Stanley maintains Global Blood Therapeutics (NASDAQ:GBT) with a Equal-Weight and raises the price target from $79 to $80.

Benzinga · 01/17/2020 13:25

Morgan Stanley maintains Global Blood Therapeutics (NASDAQ:GBT) with a Equal-Weight and raises the price target from $79 to $80.